drugset / Trial / NCT05787769
A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to evaluate the efficacy and safety of intracavernosal injection of PRP in patients with moderate to severe ED.
Timeline
- Start
- 2023-03-01
- Primary completion
- 2025-01-25
- Completion
- 2025-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Platelet Rich Plasma | Other / unclassified | 10 ml | Intrathecal |
| Comparator | Tadalafil | Small molecule | 5 mg | Oral |
Indications
No indication recorded.